HOME >> BIOLOGY >> NEWS
Growth factor may determine who grows new blood vessels that protect against heart attacks

DALLAS, August 3 -- The ability of some individuals to develop new coronary arteries that help to re-route blood flow around artery blockages might be the result of their ability to produce a growth factor, a protein that helps to generate new blood vessels, according to a paper in Circulation: Journal of the American Heart Association.

Heart specialists have long been puzzled by the fact that some patients are able to form networks of new blood vessels, called coronary artery collateral beds, whereas other patients are not. A strong collateral blood supply can help reduce the severity of heart attacks, or even prevent them, experts say.

A team of Israeli researchers has identified a possible explanation for this phenomenon. They found that the ability to grow the new vessels in the heart strongly correlates with how much vascular endothelial growth factor (VEGF) a person produces when the heart muscle receives insufficient oxygen -- a condition called hypoxia.

The Israeli team studied 51 patients, all of whom had a blockage of 70 percent or greater in at least one coronary artery. The patients underwent diagnostic angiography -- an X-ray that shows where a narrowing has occurred in an artery. These angiograms also showed researchers the extent of collateral blood supply in each patient. The patients were then divided into three groups depending on the extent of their collateral beds. The levels of VEGF were also tested.

The researchers found no significant difference in the patients' ability to produce VEGF when cells received normal levels of oxygen. However, the patients differed markedly in VEGF production when the cells got insufficient oxygen. Those patients who produced the most VEGF during hypoxia also had the most extensive collateral blood supply.

This correlation of VEGF production with the number of collateral blood vessels remained even after researchers considered factors that might adversely affect the extent of coll
'"/>

Contact: Carole Bullock
caroleb@heart.org
214-706-1279
American Heart Association
2-Aug-1999


Page: 1 2 3

Related biology news :

1. Growth hormone and IBD: Reduction of intestinal inflammation, promotion of growth
2. Growth study of wild chimpanzees challenges assumptions about early humans
3. Growth hormone activates gene involved in healing damaged tissue
4. Growth factor shows promise in Parkinsons patients
5. Growth hormone could make farm fish bigger, faster to market
6. Growth hormone may stimulate production of T cells to boost bodys ability to fight HIV
7. Growth hormone may boost production of disease-fighting cells in elderly
8. Growth factor receptor signaling critical to intestinal tumor development, studies show
9. Growth hormone involved in diabetic kidney disease, study finds
10. Report: High Carbon Dioxide Boosts Duke Forest Growth By 25 Percent
11. UC Berkeley Conference On Population Growth And The Environment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2020)... , ... February 11, 2020 ... ... to solving complex problems for life sciences companies and government agencies, announced ... years of management consulting expertise to Tunnell, with significant experience assessing, designing, ...
(Date:2/6/2020)... ... February 06, 2020 , ... ... to unique lab-made bioresearch materials, today announced an agreement with The Good ... and seafood a reality. Under the partnership, terrestrial meat and aquatic cell lines ...
(Date:1/29/2020)... ... January 29, 2020 , ... Jason Burke has joined ... practice, providing consulting services for strategy, research and development and data governance to ... and Managing Partner of CREO, an innovative management consulting and advisory firm based ...
Breaking Biology News(10 mins):
(Date:2/5/2020)... ... 2020 , ... Shoreline Biome , a microbiome research ... has announced a new distribution partnership in Asia. , The distribution partner, Gene ... and research organizations in China, Hong Kong, and Macau. , Gene Company Limited ...
(Date:1/28/2020)... (PRWEB) , ... January 28, 2020 , ... ... to be the exclusive distributor to food and beverage manufactures within North America. ... considered critical suppliers. This agreement will allow each company to pool their collective ...
(Date:1/27/2020)... ... 2020 , ... Valencell, the leading innovator in wearable biometric ... Halma plc , a FTSE 100 global group of life-saving technology companies, ... Joshua Fund. A representative from Halma will join the Valencell board of directors. ...
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal Implant CEO ... industry at two recent North American investor forums specializing in medical advancements. New ... Technologies & Diagnostics Forum on November 21, 2019 in New York City, and ...
Breaking Biology Technology:
Cached News: